Related Experiment Video
Updated: Jul 6, 2026

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis
Published on: February 16, 2015
[Apoptosis-inducing effect of alternol on mouse lymphocyte leukemia cells and its mechanism]
Zhao-zhe Liu1, Jie-peng Chen, Su-lan Zhao
1School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing 100083, China.
Abstract:
Alternol is purified from fermentation productions of microorganisms named as Alternaria alternata var. monosporus. The research is to investigate the apoptosis-inducing effect of alternol on mouse lymphocyte leukemia (L1210) cells and the possible mechanisms. MTT method was used to evaluate the viability of L1210 cells. Apoptosis of L1210 cells was detected by morphological assessment, DNA electrophoresis assay and flow cytometry. Western blotting analysis was carried out to determine the apoptosis-related proteins. Proliferation inhibition of L1210 cells by alternol was found remarkably in a dose-dependent manner. When treated with alternol, apoptotic morphological features of L1210 cells were observed by fluorescent microscopy (AO/EB) and the apoptosis rate was also elevated in a time-dependent manner. After treatments with various concentrations of alternol for 48 h, DNA laddering appeared. The increase of reactive oxygen species (ROS) production was found after cells were exposed to alternol for 6 h, while the decrease of mitochondrial transmembrane potential (delta psi m) was not found until cells were exposed to alternol for 24 h. Furthermore, the level of Bcel-2 and Bcl-2/Bax was down-regulated, while the level of caspase-3 and caspase-9 but not caspase-8 was up-regulated when alternol was added for 72 h. In summary, the results suggested that alternol could inhibit the proliferation of L1210 cells and induce apoptosis of L1210 cells, which was mediated by mitochondria-dependent pathway.
Insights
Alternol, derived from Alternaria alternata, effectively inhibits mouse leukemia L1210 cell proliferation. It induces apoptosis via a mitochondria-dependent pathway, involving reactive oxygen species and caspase activation.
Area of Science:
- Pharmacology
- Cancer Biology
- Cell Biology
Background:
- Leukemia L1210 cells are a common model for studying anti-cancer agents.
- Alternol is a compound isolated from Alternaria alternata var. monosporus.
- Understanding the mechanisms of novel compounds in inducing cancer cell apoptosis is crucial.
Purpose of the Study:
- To investigate the apoptosis-inducing effects of Alternol on mouse lymphocyte leukemia (L1210) cells.
- To elucidate the underlying mechanisms of Alternol-induced apoptosis in L1210 cells.
Main Methods:
- Cell viability was assessed using the MTT assay.
- Apoptosis was detected through morphological assessment (AO/EB staining), DNA electrophoresis, and flow cytometry.
- Western blotting was employed to analyze apoptosis-related protein expression, alongside reactive oxygen species (ROS) and mitochondrial membrane potential (Δψm) measurements.
Main Results:
- Alternol demonstrated dose-dependent inhibition of L1210 cell proliferation.
- Apoptotic morphological features, elevated apoptosis rates, and DNA laddering were observed.
- Alternol induced ROS production, decreased mitochondrial membrane potential, down-regulated Bcl-2, and up-regulated Caspase-3 and Caspase-9.
Conclusions:
- Alternol effectively inhibits L1210 cell proliferation and induces apoptosis.
- The apoptosis is mediated through a mitochondria-dependent pathway.
- Alternol shows potential as an anti-leukemic agent.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Apoptosis
The Extrinsic Apoptotic Pathway
